Abstract
Electro-responsive nanomaterials are usually made with polyelectrolytes able to undergo shrinkage or swelling by tuning on electrical fields. Nevertheless, the electrical conductivity of many polymeric materials used for the fabrication of release devices is not high enough to achieve an effective modulation of the drug release. The incorporation of conducting materials (e.g. carbon nanostructures) in polymeric networks has been proposed as a valuable strategy to overcome this limitation. In this regard, carbon nanotubes and graphene, by virtue of their unique chemical structures and attractive physiochemical properties, have been receiving exciting attention primarily in biology and medicine. By their incorporation into composite hydrogels, the biocompatibility and biodegradability of polymers can be merged with the favorable properties of carbon nanostructures, such as enhanced cellular uptake, electromagnetic, and magnetic behavior. The applicability of carbon hybrid materials to modulate release of therapeutics in response to an external current voltage, is being extensively investigated in the present review.
Keywords: Electro Responsive drug delivery, Hydrogels, Carbon Nanotubes, Graphene.Electro Responsive drug delivery, Hydrogels, Carbon Nanotubes, Graphene.
Mini-Reviews in Medicinal Chemistry
Title:Carbon Nanohybrids as Electro-Responsive Drug Delivery Systems
Volume: 16 Issue: 8
Author(s): Giuseppe Cirillo, Umile Gianfranco Spizzirri, Manuela Curcio, Silke Hampel, Orazio Vittorio, Donatella Restuccia, Nevio Picci and Francesca Iemma
Affiliation:
Keywords: Electro Responsive drug delivery, Hydrogels, Carbon Nanotubes, Graphene.Electro Responsive drug delivery, Hydrogels, Carbon Nanotubes, Graphene.
Abstract: Electro-responsive nanomaterials are usually made with polyelectrolytes able to undergo shrinkage or swelling by tuning on electrical fields. Nevertheless, the electrical conductivity of many polymeric materials used for the fabrication of release devices is not high enough to achieve an effective modulation of the drug release. The incorporation of conducting materials (e.g. carbon nanostructures) in polymeric networks has been proposed as a valuable strategy to overcome this limitation. In this regard, carbon nanotubes and graphene, by virtue of their unique chemical structures and attractive physiochemical properties, have been receiving exciting attention primarily in biology and medicine. By their incorporation into composite hydrogels, the biocompatibility and biodegradability of polymers can be merged with the favorable properties of carbon nanostructures, such as enhanced cellular uptake, electromagnetic, and magnetic behavior. The applicability of carbon hybrid materials to modulate release of therapeutics in response to an external current voltage, is being extensively investigated in the present review.
Export Options
About this article
Cite this article as:
Cirillo Giuseppe, Spizzirri Gianfranco Umile, Curcio Manuela, Hampel Silke, Vittorio Orazio, Restuccia Donatella, Picci Nevio and Iemma Francesca, Carbon Nanohybrids as Electro-Responsive Drug Delivery Systems, Mini-Reviews in Medicinal Chemistry 2016; 16 (8) . https://dx.doi.org/10.2174/1389557515666150709104444
DOI https://dx.doi.org/10.2174/1389557515666150709104444 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Drugs and mitochondria
Mitochondria play a central role in the life and death of cells. They are not merely the center for energy metabolism but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signaling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry Proteomics as Applied to Inherited Metabolic Diseases
Current Proteomics Preparation and Characterization of 5-Fluorouracil Loaded Nanogels for Skin Cancer Treatments: In Vitro Drug Release, Cytotoxicity and Cellular Uptake Analysis
Current Nanomedicine Regulation of Angiogenesis by the Small Heat Shock Protein αB-Crystallin
Current Angiogenesis (Discontinued) Molecular Aspects of FKBP51 that Enable Melanoma Dissemination
Current Molecular Pharmacology Cancer Estimates in Brazil Reveal Progress for the Most Lethal Malignancies
Current Topics in Medicinal Chemistry The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
Current Genomics New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments
Mini-Reviews in Medicinal Chemistry Chondroitin Sulphate Decorated Polymeric Nanoparticles: An Effective Carrier for Enhancement of Lung Cancer Targeting Capabilities of Anticancer Drug
Current Nanomedicine Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research The Role of JNK Signalling in Responses to Oxidative DNA Damage
Current Drug Targets A Common Molecular Motif Characterizes Extracellular Allosteric Enhancers of GPCR Aminergic Receptors and Suggests Enhancer Mechanism of Action
Current Medicinal Chemistry Impact of Renin-Angiotensin System in Hepatocellular Carcinoma
Current Cancer Drug Targets The Complex Dynamics of Breast Cancer
Current Women`s Health Reviews Hyaluronan/Hyaladherins - a Promising Axis for Targeted Drug Delivery in Cancer
Current Drug Delivery Novel Strategies of Regenerative Medicine Using Chemical Compounds
Current Medicinal Chemistry MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance
Current Medicinal Chemistry Recent Advances in Oncogenic Roles of the TRPM7 Chanzyme
Current Medicinal Chemistry Age-Related Decline in Melatonin and Its MT1 Receptor Are Associated with Decreased Sensitivity to Melatonin and Enhanced Mammary Tumor Growth
Current Aging Science Lung Transplantation: Perioperative Pharmacology and Anesthetic Considerations
Current Clinical Pharmacology